Short Videos

NEW Short Video Discussion

References:

• The low flyers: persistent airflow limitation in young adults. Lancet Respir Med. 2022; S2213-2600: 00250-8
• Small airways and early origins of COPD: pathobiological and epidemiological considerations. Eur Respir J 2020; 55: 1902457

---

Time to Breathe

References:

• How COVID-19 interacts with interstitial lung disease. Breathe 2022 18: 210158

---

References:

• Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy. Breathe 2021; 17: 210112

---

Short Video Discussion

References:

• Using pulmonary gas exchange to estimate shunt and deadspace in lung disease: theoretical approach and practical basis. Journal of Applied Physiology 2022; 132: 1104-1113

---

References:

• ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J 2021; 58: 2004079

---

References:

• ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 2020; 55: 1901136
• Angiotensin-converting enzyme and the cough reflex. Lancet 1987; 2: 1116-1118
• Cough hypersensitivity syndrome: a distinct clinical entity. Lung 2011; 189: 73-79
• Hull Airway Reflux Questionnaire. International Society for the Study of Cough

---

References:

• Allergen Provocation Tests in Respiratory Research: Building on 50 Years of Experience. Eur Respir J 2022; 59: 2102782
• Provoked models of asthma: what have we learnt? Clin Exp Allergy 2009; 39: 181-92
• The links between allergen skin test sensitivity, airway responsiveness and airway response to allergen. Allergy 2005; 60: 56-9
• Inhaled allergen bronchoprovocation tests. J Allergy Clin Immunol 2013; 132: 1045-1055
• ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J 2017; 49: 1601526
• ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing. Eur Respir J 2018; 52: 1801033

---

References:

• Portable Oxygen Concentrators (POCs) by Chris Garvey

---

References:

• European Respiratory Society statement on thoracic ultrasound. Eur Respir J 2021; 57: 2001519
• A systematic review of comorbidities and outcomes of adult patients with pleural infection. Eur Respir J 2019; 54: 1900541
• Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection. N Engl J Med 2011; 365: 518-526

---

References:

• Sleep-related breathing disturbance, Somnologie 2017; 20 (s2): S97-S180 (GERMAN)
• Obstructive sleep apnoea in the general population: highly prevalent but minimal symptoms. Eur Respir J. 2016; 47: 194-202
• Challenges and perspectives in obstructive sleep apnoea: Report by an ad hoc working group of the Sleep Disordered Breathing Group of the European Respiratory Society and the European Sleep Research Society.  Eur Respir J 2018; 52: 1702616

---

---

References:

• CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation. Radiology 2020; 296: E97-E104
• Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J 2021; 57: 2003481
• Chest CT in COVID-19: What the Radiologist Needs to Know. Radiographics 2020; 40: 1848-1865
• Pulmonary fibrosis secondary to COVID-19: a call to arms?. Lancet Respir Med 2020; 8: 750-752
• Pericardial effusion in patients with COVID-19: case series. Eur Heart J Case Rep. 2020; 4): 1–7
• British Thoracic Society Guidance on Respiratory Follow Up of Patients with a Clinico-Radiological Diagnosis of COVID-19 Pneumonia.

---

References:

• Randomised controlled trial of cognitive behavioural therapy in COPD. ERJ Open Res. 2018; 4: 00094-2018

---

References:

• Asthma in the Time of COVID-19. Am J Respir Crit Care Med 2021; 203: 785–786
• Asthma and COVID-19: Preconceptions about Predisposition. Am J Respir Crit Care Med. 2021; 203: 799–801
• Asthma-associated risk for COVID-19 development. J Allergy Clin Immunol 2020; 146: 1295-1301
• Asthma and COVID-19; different entities, same outcome: a meta-analysis of 107,983 patients. Journal of Asthma 2021
• Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020; 146: 203–206.e3
• Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol 2020; 146: 1-7
• Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement. Allergy 2020; 75: 2764-2774

---

References:

• Artificial intelligence techniques in asthma: a systematic review and critical appraisal of the existing literature. Eur Respir J 2020; 56: 2000521
• Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests. Eur Respir J 2019; 53: 1801660
• Machine Learning and Data Mining Methods in Diabetes Research. Comput Struct Biotechnol J. 2017; 15: 104-116
• Latent bias and the implementation of artificial intelligence in medicine. J Am Med Inform Assoc 2020; 27: 2020-2023
• End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat Med 2019; 25: 954-961

---

References:

• Adherence to Continuous Positive Airway Pressure Therapy. Proc Am Thorac Soc. 2008;  5: 173–178
• CPAP improves social, emotional and sexual scope of obstructive sleep apnea patients and partners. European Respiratory Journal 2020 56: 2142
• Novel Aspects of CPAP Treatment and Interventions to Improve CPAP Adherence. J Clin Med 2019; 8: 2220

---

References:

• Exercise interventions in solid organ transplant candidates: A systematic review. Clin Transplant 2020; 34: e13900
• Changes in 6‐minute walking distance in lung transplant candidates while participating in a home‐based pre‐habilitation program—A retrospective chart review. Clin Transplant 2020; 34: e14045
• The effectiveness of prehabilitation or preoperative exercise for surgical patients: a systematic review. JBI Database System Rev Implement Rep 2015; 13: 146-87

---

---

Short Video Statements

References:

• Airway clearance techniques in neuromuscular disorders: A state of the art review. Respir Med 2018; 136: 98-110
• 228th ENMC International Workshop: Airway clearance techniques in neuromuscular disorders Naarden, The Netherlands, 3-5 March 2017. Neuromuscul Disord 2018; 28: 289-298

---

References:

• Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis, ESMO Open. 2020; 5: e000947
• Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19), Eur J Cancer 2020; 141: 62-81
• COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study, Lancet Oncol 2020; 21: 914–22
• COVID-19 in patients with lung cancer, Ann Oncol 2020; 10:1386-1396

---

References:

• Pulmonary alveolar proteinosis, Nature Reviews Disease Primers 2019; 5: 16
• Inhaled GM-CSF for Pulmonary Alveolar Proteinosis, N Engl J Med 2019; 381:923-932
• Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis, N Engl J Med 2020; 383:1635-1644

---

References:

• ESR/ERS statement paper on lung cancer srcreening
• ESR/ERS white paper on lung cancer screening
• European position statement on lung cancer screening

---

References:

• Mepolizumab or placebo for Eosinophilic Granulomatosis with Polynagiitis
• Rituximab as induction therapy in EGPA refractory to conventional immunosuppressive treatment: A 36 month follow up analysis

---

References:

• Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review
• Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
• Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

---

COVID-19